Association between bisphenol exposure and polycystic ovary syndrome risk: an integrated systematic review and meta-analysis

• by Zongying Gui, Huizhen Lin, Chuhan Wang, Yingsha Yao

• June 11, 2026

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

• by Kathryn Wighton

• May 21, 2026

• 2 min

Differences in clinical characteristics and cardiovascular disease risk prediction among Chinese women with polycystic ovary syndrome phenotypes: a cross-sectional study

• by Ziye Gong, Danyang Li, Xuan Li, Jinjin Tian, Jing Guo, Yuying Zhao, Yin Lu, Shan Gao, Ming Li

• April 10, 2026

Evidence-based interventions to restore or improve female fertility in women aged 30–42 years: a systematic review by etiology and evidence level

• by Maria Jimena Barroso Alverde, Sion Yu, Daniel Pascal Pontón, Denise Niza Benardete Harari, José Elias Tesone Lasman

• June 9, 2026